开云app官网登录入口网页版-官方正版

#ASIA#

71篇内容 | 1515人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1780123, encodeId=868c1e80123a4, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle= 热烈庆祝吉适研究壁报在IMCAS Asia大会, objectType=article, longId=294835, objectId=ebda29483525, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ebda29483525, replyNumber=0, likeNumber=71, createdTime=2022-02-23, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ebda29483525, moduleTitle= 热烈庆祝吉适研究壁报在IMCAS Asia大会, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ebda29483525)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780122, encodeId=c5581e8012235, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=JACC-Asia：来自CHERRY研究的结果：中国动脉粥样硬化心血管风险预测模型的评价, objectType=article, longId=293788, objectId=e58e293e8852, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e58e293e8852, replyNumber=0, likeNumber=83, createdTime=2022-07-27, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e58e293e8852, moduleTitle=JACC-Asia：来自CHERRY研究的结果：中国动脉粥样硬化心血管风险预测模型的评价, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e58e293e8852)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780117, encodeId=b31a1e80117ed, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Asian Pac J Allergy Immunol：中国武汉COVID-19大流行期间过敏性鼻炎患者的焦虑和抑郁情况 , objectType=article, longId=208904, objectId=cf89208904fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf89208904fb, replyNumber=0, likeNumber=60, createdTime=2021-11-16, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf89208904fb, moduleTitle=Asian Pac J Allergy Immunol：中国武汉COVID-19大流行期间过敏性鼻炎患者的焦虑和抑郁情况 , moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=cf89208904fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780119, encodeId=c3f91e801197c, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Solasia宣布在日本提交抗癌药物DARINAPARSIN用于外周T细胞淋巴瘤的新药申请, objectType=article, longId=213648, objectId=33d021364893, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33d021364893, replyNumber=0, likeNumber=98, createdTime=2021-10-08, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33d021364893, moduleTitle=Solasia宣布在日本提交抗癌药物DARINAPARSIN用于外周T细胞淋巴瘤的新药申请, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=33d021364893)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780118, encodeId=3b411e801181b, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Asian Pac J Allergy Immunol：非索非那定/伪麻黄碱复方药片对过敏性鼻炎患者鼻塞的治疗效果 , objectType=article, longId=209037, objectId=c09520903e22, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c09520903e22, replyNumber=0, likeNumber=66, createdTime=2021-12-17, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c09520903e22, moduleTitle=Asian Pac J Allergy Immunol：非索非那定/伪麻黄碱复方药片对过敏性鼻炎患者鼻塞的治疗效果 , moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c09520903e22)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780121, encodeId=41f51e80121ca, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Asian Pac J Allergy Immunol：富马酸卢帕他定治疗常年过敏性鼻炎的疗效和安全性, objectType=article, longId=214936, objectId=73c621493629, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73c621493629, replyNumber=0, likeNumber=65, createdTime=2022-01-25, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73c621493629, moduleTitle=Asian Pac J Allergy Immunol：富马酸卢帕他定治疗常年过敏性鼻炎的疗效和安全性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=73c621493629)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780120, encodeId=0f7b1e8012042, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=热烈庆祝吉适研究壁报在IMCAS Asia大会, objectType=article, longId=214280, objectId=056f2142805b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=056f2142805b, replyNumber=0, likeNumber=72, createdTime=2021-12-29, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=056f2142805b, moduleTitle=热烈庆祝吉适研究壁报在IMCAS Asia大会, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=056f2142805b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780116, encodeId=48cb1e8011608, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Asian Pac J Allergy Immunol：TLR4 rs1927911多态性与屋尘螨致敏在过敏性鼻炎中的相互作用及其预后情况 , objectType=article, longId=205417, objectId=405d20541e98, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=405d20541e98, replyNumber=0, likeNumber=56, createdTime=2021-07-25, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=405d20541e98, moduleTitle=Asian Pac J Allergy Immunol：TLR4 rs1927911多态性与屋尘螨致敏在过敏性鼻炎中的相互作用及其预后情况 , moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=405d20541e98)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780115, encodeId=6e741e801152a, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Neoplasia ：公布PARP抑制剂晚期卵巢2期临床数据，有望为患者开启“去化疗”治疗新时代, objectType=article, longId=200929, objectId=978320092943, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=978320092943, replyNumber=0, likeNumber=74, createdTime=2021-04-06, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=978320092943, moduleTitle=Neoplasia ：公布PARP抑制剂晚期卵巢2期临床数据，有望为患者开启“去化疗”治疗新时代, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=978320092943)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780109, encodeId=26381e8010976, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=ESMO ASIA |如何管理免疫相关不良事件, objectType=article, longId=183916, objectId=ed0d183916bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed0d183916bb, replyNumber=0, likeNumber=55, createdTime=2020-04-16, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed0d183916bb, moduleTitle=ESMO ASIA |如何管理免疫相关不良事件, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ed0d183916bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780111, encodeId=1aac1e80111d3, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Asian Pac J Allergy Immunol：高风险阻塞性睡眠呼吸暂停在过敏性鼻炎患者中的患病率研究, objectType=article, longId=184306, objectId=797318430685, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=797318430685, replyNumber=0, likeNumber=65, createdTime=2020-06-19, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=797318430685, moduleTitle=Asian Pac J Allergy Immunol：高风险阻塞性睡眠呼吸暂停在过敏性鼻炎患者中的患病率研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=797318430685)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780114, encodeId=4e871e8011454, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Asian Pac J Allergy Immunol：鼻内皮质激素治疗中度到重度阻塞性睡眠呼吸暂停且并发慢性鼻炎患者的效果研究, objectType=article, longId=200355, objectId=a36620035590, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a36620035590, replyNumber=0, likeNumber=87, createdTime=2020-09-16, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a36620035590, moduleTitle=Asian Pac J Allergy Immunol：鼻内皮质激素治疗中度到重度阻塞性睡眠呼吸暂停且并发慢性鼻炎患者的效果研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a36620035590)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780112, encodeId=6c4e1e801123e, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Asia Pac J Clin Nutr：更高的血清镁离子浓度值与更低的听力阈值和听力损失风险相关, objectType=article, longId=185525, objectId=b030185525a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b030185525a0, replyNumber=0, likeNumber=68, createdTime=2020-11-18, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b030185525a0, moduleTitle=Asia Pac J Clin Nutr：更高的血清镁离子浓度值与更低的听力阈值和听力损失风险相关, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b030185525a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780113, encodeId=c7761e801137e, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Asian J Androl：定期的阴茎根自慰或可有效治疗原发性早泄, objectType=article, longId=188903, objectId=452218890318, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=452218890318, replyNumber=0, likeNumber=71, createdTime=2020-07-30, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=452218890318, moduleTitle=Asian J Androl：定期的阴茎根自慰或可有效治疗原发性早泄, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=452218890318)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780108, encodeId=5c051e801084b, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=ESMO Asia|达可替尼大大改善OS，亚裔和21 L858R突变患者均显著获益, objectType=article, longId=183915, objectId=0fd9183915be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0fd9183915be, replyNumber=0, likeNumber=66, createdTime=2020-03-18, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0fd9183915be, moduleTitle=ESMO Asia|达可替尼大大改善OS，亚裔和21 L858R突变患者均显著获益, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0fd9183915be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780107, encodeId=2db51e8010731, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=2019 ESMO ASIA |胃食管癌免疫治疗的现在和未来, objectType=article, longId=183907, objectId=3dfe18390e65, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3dfe18390e65, replyNumber=0, likeNumber=60, createdTime=2020-10-25, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3dfe18390e65, moduleTitle=2019 ESMO ASIA |胃食管癌免疫治疗的现在和未来, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3dfe18390e65)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780104, encodeId=624e1e8010417, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Asian Pac J Allergy Immunol：青葱的抗过敏活性和治疗过敏性鼻炎效果研究, objectType=article, longId=178302, objectId=5b4f1e8302fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b4f1e8302fc, replyNumber=0, likeNumber=70, createdTime=2019-09-10, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b4f1e8302fc, moduleTitle=Asian Pac J Allergy Immunol：青葱的抗过敏活性和治疗过敏性鼻炎效果研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=5b4f1e8302fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780103, encodeId=409a1e80103f3, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Asian Pac J Allergy Immunol：蒸汽吸入法对过敏性鼻炎患者鼻塞影响研究, objectType=article, longId=169030, objectId=4a3916903094, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a3916903094, replyNumber=0, likeNumber=59, createdTime=2019-10-18, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a3916903094, moduleTitle=Asian Pac J Allergy Immunol：蒸汽吸入法对过敏性鼻炎患者鼻塞影响研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=4a3916903094)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780110, encodeId=89951e8011066, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=【ESMO ASIA】中国数据助力亚洲乳腺癌辅助治疗新标准, objectType=article, longId=184049, objectId=efd4184049ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=efd4184049ed, replyNumber=0, likeNumber=68, createdTime=2020-07-12, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=efd4184049ed, moduleTitle=【ESMO ASIA】中国数据助力亚洲乳腺癌辅助治疗新标准, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=efd4184049ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780100, encodeId=4b281e801003c, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=2019年AsiaTIDES：Sirnaomics将展示RNAi药物STP705在肝癌动物模型中的数据 , objectType=article, longId=161220, objectId=bd21161220d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd21161220d3, replyNumber=0, likeNumber=67, createdTime=2019-04-12, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd21161220d3, moduleTitle=2019年AsiaTIDES：Sirnaomics将展示RNAi药物STP705在肝癌动物模型中的数据 , moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=bd21161220d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

ASIA

2020-05-29

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

热烈庆祝吉适研究壁报在IMCAS Asia大会

2022-02-23

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

JACC-Asia：来自CHERRY研究的结果：中国动脉粥样硬化心血管风险预测模型的评价

2022-07-27

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Asian Pac J Allergy Immunol：中国武汉COVID-19大流行期间过敏性鼻炎患者的焦虑和抑郁情况

2021-11-16

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Solasia宣布在日本提交抗癌药物DARINAPARSIN用于外周T细胞淋巴瘤的新药申请

2021-10-08

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Asian Pac J Allergy Immunol：非索非那定/伪麻黄碱复方药片对过敏性鼻炎患者鼻塞的治疗效果

2021-12-17

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Asian Pac J Allergy Immunol：富马酸卢帕他定治疗常年过敏性鼻炎的疗效和安全性

2022-01-25

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

热烈庆祝吉适研究壁报在IMCAS Asia大会

2021-12-29

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Asian Pac J Allergy Immunol：TLR4 rs1927911多态性与屋尘螨致敏在过敏性鼻炎中的相互作用及其预后情况

2021-07-25

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Neoplasia ：公布PARP抑制剂晚期卵巢2期临床数据，有望为患者开启“去化疗”治疗新时代

2021-04-06

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

ESMO ASIA |如何管理免疫相关不良事件

2020-04-16

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Asian Pac J Allergy Immunol：高风险阻塞性睡眠呼吸暂停在过敏性鼻炎患者中的患病率研究

2020-06-19

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Asian Pac J Allergy Immunol：鼻内皮质激素治疗中度到重度阻塞性睡眠呼吸暂停且并发慢性鼻炎患者的效果研究

2020-09-16

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Asia Pac J Clin Nutr：更高的血清镁离子浓度值与更低的听力阈值和听力损失风险相关

2020-11-18

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Asian J Androl：定期的阴茎根自慰或可有效治疗原发性早泄

2020-07-30

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

ESMO Asia|达可替尼大大改善OS，亚裔和21 L858R突变患者均显著获益

2020-03-18

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

2019 ESMO ASIA |胃食管癌免疫治疗的现在和未来

2020-10-25

智慧医人 (审核中...)

前往app查看评论内容

#ASIA#

Asian Pac J Allergy Immunol：青葱的抗过敏活性和治疗过敏性鼻炎效果研究

2019-09-10

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Asian Pac J Allergy Immunol：蒸汽吸入法对过敏性鼻炎患者鼻塞影响研究

2019-10-18

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

【ESMO ASIA】中国数据助力亚洲乳腺癌辅助治疗新标准

2020-07-12

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

2019年AsiaTIDES：Sirnaomics将展示RNAi药物STP705在肝癌动物模型中的数据 

2019-04-12

科室
- - 订阅+
  - 更多科室
工具
服务